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Nuclear hormone receptors (NHRs) represent a large and diverse family of ligand-activated transcription
factors involved in regulating development, metabolic homeostasis, salt balance and reproductive health.
The ligands for these receptors are typically small hydrophobic molecules such as steroid hormones, thyroid
hormone, vitamin D3 and fatty acid derivatives.The first NHR structural information appeared ~20 years ago
with the solution and crystal structures of the DNA binding domains and was followed by the structure of the
agonist and antagonist bound ligand binding domains of different NHR members. Interestingly, in addition
to these defined structural features, it has become clear that NHRs also possess significant structural plasticity.
Thus, the dynamic structure of the NHRs was the topic of a recent stimulating and informative FASEB Summer
Research Conference held in Vermont.
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Introduction
Those in the nuclear receptor field are well acquainted
with the domain organisation of the nuclear hormone
receptors (NHRs) and easily recognise the globular
canonical structures of the isolated DNA and ligand
binding domains (Figure 1, DBD and LBD, respectively).
The first DBD structures appeared in the early 1990s
[Hard et al., 1990; Schwabe et al., 1993] and were
followed a few years later by LBD crystal structures
[Brzozowski et al., 1997; Renaud et al., 1995]. Since then,
structures have been solved for the DBDs and LBDs of
at least one member of nearly all NHR subclasses.
Currently, there are over 300 structures deposited with
the NCBI structure database that confirm the universal
nature of the canonical folds of the isolated DBD and LBD
(Figure 1) and the high degree of identity that is observed
in the primary amino acid sequence. However, what is
now emerging, and was emphasised at this meeting, is
how these domains interact in the context of the full-length
receptor complex and how different ligands (Figure 1:
hormones, DNA response elements, and coregulatory
proteins) allosterically modulate these canonical
structures leading to subtle, but functionally important
changes in conformation.
Allosteric regulation and biological
specificity take centre stage
In the keynote address, Keith Yamamoto (UCSF)
discussed his group’s recent work, which elegantly
emphasised the allosteric role of glucocorticoid receptor
DNA binding sites (GBS) [Meijsing et al., 2009].Whole
genome analysis by ChIP-chip had previously revealed
that glucocorticoid receptor binding was cell-type specific
and that individual DNA binding sites were conserved
across species, but also displayed considerable variation
in DNA sequence. In the latest study, Yamamoto and
coworkers reported on the structure-function relationships
of a number of GBS with slightly different DNA
sequences.Two important messages arose from these
biochemical and structural studies: (1) there is not a
simple relationship between the affinity of the receptor
for a DNA response element and its transcriptional
activation and (2) binding to different DNA sequences
causes the region between the recognition helix and
D-box, termed the lever arm, to adopt different
conformations.Yamamoto went on to discuss how these
DNA-induced conformational differences could result in
the formation of distinct interaction surfaces and modulate
receptor activity.The role of DNA binding and domain
interactions was further explored by Fraydoon Rastinejad
(University of Virginia) in his presentation of the structure
of the PPARγ-RXR heterodimer bound to a DR1 response
element [Chandra et al., 2008].Thus, for the first time,
information is now available on the structure of full-length
receptors bound to DNA and coregulatory peptides.The
key features of these structures are: (1) the degree of
domain interaction between the PPARγ LBD with its own
DBD, the RXR-DBD and the RXR-LBD, (2) the polarity
of the complex with PPAR occupying the 5’ half site, (3)
the more open conformation of RXR in the complex, and
(4) less surprising, but significant in light of the other
interactions identified, was the confirmed disordered
nature of the N-terminal domain.What both these studies
emphasised is that, despite the universal nature of DBD
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different DNA binding sites and to understand how the
domains in the intact receptor interact when assembled
on DNA.
Figure 1.  Structural and functional domains of nuclear hormone
receptors. The basic domain organisation of a nuclear hormone receptor
(NHR) is shown: LBD, ligand binding domain; DBD, DNA binding domain;
and AF1 and AF2, activation functions 1 and 2 in the NTD and LBD,
respectively. Above the NHR schematic are examples of allosteric
modulators of NHR structure and function.These include ligands such
as the vitamin A derivative retinoic acid and the steroid hormone cortisol,
which bind to the LBD. NHRs interact with DNA response elements (RE),
which can also induce allosteric changes in receptor structure/function.
Coregulatory proteins have been described that bind to the AF2 in the
LBD, AF1 in the NTD, and the DBD and may have allosteric effects on
NHR conformation. Below the NHR schematic is a plot illustrating the
presence of the intrinsically disordered structure within the NTD (Score
above 0.5, Yang et al 2005) and the globular, canonical structures of the
isolated DBD and LBD.
The structural basis for ligand binding and specificity of
receptor response was considered in presentations by
Geoffrey Greene (University of Chicago) and Edward
Zhou (Xu Lab, Van Andel Research Institute).
Interestingly, the ligand discrimination and specific activity
of estrogen receptors α and β involve residues in the
ligand binding pocket, as well as secondary structural
elements adjacent to, and distant from, the pocket [Nettles
et al., 2008].The importance of ligand binding for
differential physiological actions of the NHRs was further
explored by Stoney Simons (NIDDK/NIH). Using
glucocorticoid receptor signaling as an example, he
demonstrated the value of considering steroid potency
(EC50 value) in addition to the maximal response
(efficacy), and considered how these parameters can be
modulated by the presence of coregulatory proteins [Luo
and Simons, 2009]. As with DNA binding, it was noted
that the affinity of NHRs for different hormonal ligands
did not relate directly to the maximal response or
coregulatory protein binding.
Domain interactions and receptor dimerization were also
illustrated in a talk by Robert Fletterick (UCSF), whose
group recently solved the structure of the LBD of liver
receptor homolog 1 (LRH-1) and an unusual member of
the NHR superfamily, Dax-1, which lacks a DBD and acts
as a repressor of different NHRs. Dax-1 dimers bind to
LRH-1 forming a trimeric complex with the repressor helix
of one Dax-1 monomer binding to the AF-2 surface of the
LRH-1 LBD [Sablin et al., 2008].
Structural plasticity of the NHR
N-terminal domain (NTD)
The functionally important NTD continues to pose a
structural challenge.There is considerable experimental
evidence that this domain is intrinsically disordered
(Figure 1; [Kumar and Thompson, 2003; McEwan et al.,
2007].The low sequence complexity and
underrepresentation of hydrophobic amino acids and the
functional relevance of intrinsically disordered proteins
or domains was considered by Chris Oldfield (Dunker
Lab, Indiana University). New insights into the regulation
of the stability and folding of the progesterone,
glucocorticoid, androgen and mineralocorticoid receptor
NTDs were discussed by Dean Edwards (Baylor College
of Medicine), Raj Kumar (TCMC, Scranton), Michael
Garabedian (NYU, College of Medicine) and Iain McEwan
(University of Aberdeen, UK).The structural plasticity of
this domain appears to be functionally important, as this
domain is involved in multiple transient protein-protein
interactions and contains sites for posttranslational
modification (i.e., phosphorylation, sumoylation).The
regulation of protein folding through coupled
protein-protein interactions and posttranslational
modification were key themes in the above talks ([Garza
et al., 2009] and references therein). Evidence for the
possible existence of folded intermediates and regions
of stable structure within the NTD of the androgen and
mineralocorticoid receptors was also presented [Lavery
and McEwan, 2008]. Another exciting development in
understanding the structure-function of the NTD is the
ability to model the intrinsic disorder, leading to the
hypothesis that the flexibility of this region is an
evolutionary adaptation that helps to keep NHRs in a
poised state, ready to respond to coregulatory proteins
after binding to hormone and DNA (Vince Hilser,
UTMB-Galveston) [Hilser and Thompson, 2007].
An important probe for stabilizing or inducing structure in
the NTD of the NHRs is the natural osmolyte
trimethylamine N-oxide (TMAO).TMAO belongs to a
family of small organic molecules including sacrosine and
sucrose that are used by organisms from bacteria to
humans to maintain cell volume and protein
structure/function under stress conditions.The
mechanism of action and thermodynamic basis for the
action of osmolytes on protein folding was discussed by
Wayne Bolen (UTMB-Galveston). Compounds such as
TMAO are found in elasmobranchs like sharks, as well
as the kidney medulla and, due to their solvophobic
properties, act by increasing free energy of the denatured
state, making it less favourable than the native state
[Auton et al., 2008].This drives protein folding through
the formation of hydrogen bonds within the peptide
backbone, without affecting the amino acid side chains
or protein function.TMAO increases both α-helical
secondary structure and folding of the glucocorticoid and
androgen receptor NTDs and enhances target protein
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McEwan et al., 2007].
Intrinsic disorder is not restricted to the NHRs, but
appears to be a common feature of eukaryotic
transcriptional machinery including transcription factors,
coactivators (for example CREB-binding protein and p160
proteins) and corepressors (for example NCoR and
SMRT). Jane Dyson (Scripps Research Institute)
illustrated the value of NMR to study intrinsic disorder
and discussed recent work on the structural basis for
IκB-NFκB interactions [Cervantes et al., 2009]. Strikingly,
the corepressors NCoR and SMRT are almost entirely
predicted to be intrinsically disordered.The structural
basis for the assembly of different multi-protein repressor
complexes by discrete domains within these proteins was
presented by John Schwabe (University of Leicester, UK)
[Codina et al., 2005].
You are never alone in a complex
NHRs are intimately involved in the transient assembly
and disassembly of protein complexes at the promoter
and/or enhancer elements of hormone-regulated genes.
Given the active role DNA binding is likely to play in NHR
action, Ann Nardulli and coworkers (University of Illinois)
used the DNA-bound estrogen receptor to isolate
receptor-interacting protein complexes. By then identifying
the individual components of the complexes, they were
able to define novel protein networks and cellular
processes regulated by the receptor [Schultz-Norton et
al., 2008].The assembly of complexes at
estrogen-regulated genes was also discussed by Mike
Stallcup (University of Southern California). His
presentation focused on NHR interacting proteins that
coordinate the recruitment of complexes with different
enzymatic activities, for example Flightless-I protein and
the SWI/SNF chromatin remodeling complex [Jeong et
al., 2009].The regulation of enzymatic activity of
complexes containing the androgen receptor and lysine
demethylation enzymes formed at androgen-regulated
genes was the theme for Roland Schüle (University of
Freiburg, Germany) [Wissmann et al., 2007].This work
revealed the exciting possibility that the substrate
specificities for the different enzymatic activities in
receptor recruited complexes can be differentially
regulated. David Lonard (O’Malley Lab, Baylor College
of Medicine) focused on the p160 family of coactivators
and discussed recent studies in which the roles of these
proteins are being defined in normal physiology and in
disease.Taken together, the findings from these groups
and others are beginning to explain why so many
coactivators and enzymatically-active complexes interact
with NHRs and reveal the possibility of additional
regulation and cross talk during development and adult
life.
A glimpse of protein folding and NHR
dynamics inside cells
In an exciting series of presentations, the participants
learned of novel approaches to studying protein folding
in cells (Lila Gierasch, University of Massachusetts), the
potential to rescue a folding-defective mutation of the
glucocorticoid receptor in situ (Brad Thompson,
UTMB-Galveston), and the role of HMG chaperone
proteins in the binding of DNA by NHRs and other
transcription factors (Mair Churchill, University of
Colorado; Jean Thomas, University of Cambridge).
Gierasch illustrated how protein engineering and novel
chemical probes could be used to follow protein
folding/unfolding in the macromolecular-crowded
environment of the cell.The biarsenical-based fluorophore
4’,5’-bis (1,3,2-dithioarsolan-2-yl)fluorescein (FIAsH) binds
to the amino acid sequence Cys-Cys-X-X-Cys-Cys (where
X is any amino acid), and, when incorporated into a
protein of interest, it was found that the fluorescence
(quantum yield) was a powerful read out of
folding/unfolding of the protein. Gierasch and co-workers
have gone on to create ‘split-tetra cys motifs’ with the
idea that the dye binds only to the folded polypeptide
[Krishnan and Gierasch, 2008].The availability of such
chemical probes, together with recent advancements in
NMR technology [Burz and Shekhtman, 2009], opens up
real possibilities for investigating folding/unfolding of
NHRs in the context of the cellular environment and
relating these findings to the wealth of in vitro data that
already exists. Sam John (Hager Lab, NIH) presented
recent findings on the interaction of the glucocorticoid
receptor with chromatin using both a single cell model
containing an engineered MMTV array and genome-wide
analysis by ChIP-seq and DNase I hypersensitivity. Using
these approaches, it was possible to distinguish, in
different cell types, inducible and constitutive DNase
hypersensitive binding sites for the receptor and to identify
a requirement for different chromatin remodeling
complexes at different sites throughout the genome [John
et al., 2008].
Pathophysiology and NHRs
NHRs have long been important clinical targets and
several speakers highlighted the translational potential
of their research. Marianne Sadar (BC Cancer Agency)
described the isolation of several natural compounds from
a marine organism, which were able to modulate
androgen receptor signaling in cell culture and tumour
growth in a mouse model. Kim Kemper (University of
Illinois) elegantly demonstrated how biochemical and cell
biology studies on posttranslational modification
(acteylation) of NHRs could lead to dysregulation of
receptor function in metabolic disease. Ongoing and
future work from these groups will further explore the
mechanistic basis of these effects and define how these
discoveries could benefit prostate cancer patients and
patients presenting with the wide spectrum of metabolic
syndrome disorders.
Ron Margolis (NIDDK, NIH) closed the meeting with a
broad discussion of the Nuclear Receptor Signaling Atlas
(NURSA). NURSA (http://www.nursa.org) is an
interdisciplinary project that provides a valuable resource
of methods and experimental data, together with short
‘biographies’ of individual NHRs, tutorials for students
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Future studies
To fully understand the mechanism of action and the
regulation of NHRs in normal physiology and disease
states, it will be necessary to consider the cellular
environment and the allosteric effects of different ligands
(hormones, DNA and binding partners).Thus, outstanding
questions concern the in vivo folding of the receptor
protein and the dynamic nature of NHR structure.The
development and application of new techniques, together
with cross-disciplinary collaborations, will assist
researchers in the NHR field in answering these
questions.The FASEB Summer Conference on Dynamic
Structure of the Nuclear Hormone Receptors is possibly
unique in the NHR arena in that it has a strong focus on
the structural dynamics of the receptor proteins that
underpin their action in health and disease. Another
unique aspect of the meeting is that it encourages
investigators with different scientific backgrounds to
actively participate and so leads to wider-reaching
discussions and, in some cases, active, new
collaborations.The 2009 meeting was considered a great
success by those who participated.
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